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Abstract. The recent outbreak of Ebola virus disease (EVD) interrupted mass drug administration (MDA) programs
to control and eliminate neglected tropical diseases in Liberia. MDA programs treat entire communities with medication
regardless of infection status to interrupt transmission and eliminate lymphatic filariasis and onchocerciasis. Following
reports of hostilities toward health workers and fear that they might be spreading EVD, it was important to determine
whether attitudes toward MDA might have changed after the outbreak. We surveyed 140 community leaders from 32 vil-
lages in Lofa County, Liberia, that had previously participated in MDA and are located in an area that was an early epi-
center of the EVD outbreak. Survey respondents reported a high degree of community trust in the MDA program, and
97% thought their communities were ready to resume MDA. However, respondents predicted that fewer people would
comply with MDA after the EVD epidemic than before. The survey also uncovered fears in the community that EVD
and MDA might be linked. Respondents suggested that MDA programs emphasize to people that the medications are
identical to those previously distributed and that MDA programs have nothing to do with EVD.
INTRODUCTION
Liberia is a post-conflict country in West Africa with a pop-
ulation of approximately 4.3 million. Like many other coun-
tries in sub-Saharan Africa, Liberia is endemic for a number
of neglected tropical diseases (NTDs) that disproportionately
affect poor populations in rural areas. Liberia’s national NTD
control and elimination program prioritizes onchocerciasis,
lymphatic filariasis (LF), schistosomiasis, soil-transmitted
helminth infections (STH), leprosy, and buruli ulcer, and it
has only recently been scaled-up to reach all of the country’s
at-risk population. The program is using mass drug adminis-
tration (MDA) with albendazole and ivermectin to eliminate
LF and onchocerciasis.1 The national LF program conducted
its first two annual MDA campaigns with albendazole and
ivermectin in 2012 and 2013. The program achieved 100%
MDA geographic coverage with albendazole and ivermectin
for LF and ivermectin for onchocerciasis in all 13 and
15 endemic counties, respectively.2 The national NTD pro-
gram director reported treatment coverage for both LF and
onchocerciasis was approximately 82% in 2012 and 2013.
The Death to Onchocerciasis and Lymphatic Filariasis
(DOLF) project has conducted an integrated NTD research
project together with the Liberian Institute for Biomedical
Research (LIBR) and the Liberian Ministry of Health and
Social Welfare since 2012. The project compares the impact
of annual and semiannual MDAwith ivermectin, albendazole,
and praziquantel on LF, onchocerciasis, STH, and schistoso-
miasis in 32 villages that are distributed around Foya town,
the capital of Foya District in Lofa County.
Liberia is one of three West African countries that were
severely affected by an outbreak of Ebola virus disease (EVD)
that started in Guinea in late 2013. On March 30, 2014, the
first two cases of EVD in Liberia were confirmed in Foya
town in Lofa County, near Liberia’s borders with Guinea
and Sierra Leone.3 Lofa County went on to become an early
epicenter of EVD in Liberia. A peak of 133 patients were
admitted to the Ebola treatment unit in Foya during the
week of August 16, 2014.4 By the end of the outbreak, a
total of 332 confirmed cases and 451 confirmed or probable
EVD deaths were reported in Lofa County.5 However, the
health impact of the outbreak extended beyond cases of EVD,
because it drained resources away from other essential health
programs. As the health system became exclusively focused
on combating the outbreak, bed nets for malaria prevention,
MDA for NTDs, and vaccines were not delivered, and com-
munity health workers were seconded to the front lines of out-
break control. This indirect impact of EVD on public health
services in Liberia, Sierra Leone, and Guinea is believed to
have caused more deaths than EVD itself. For example, one
study estimated that the disruption of malaria control and
care programs may have resulted in an additional 3.5 million
untreated malaria cases and 10,900 malaria-attributed deaths
in 2014 in Liberia, Guinea, and Sierra Leone.6
Now that the outbreak is mostly under control and isolated
to small geographical hotspots in Guinea and Sierra Leone,
it is important that these countries’ health systems resume
public health programs that were suspended during the EVD
epidemic. However, there is evidence that communities’ atti-
tudes toward the health system were altered by the EVD
outbreak. During the outbreak, there were many reports of
hostility toward health workers and even attacks on them,
because some people feared that health workers were
responsible for spreading EVD.7,8 An improved understanding
of communities’ attitudes regarding public health personnel
and programs after the EVD outbreak may improve chances
for smooth resumption of these public health programs. There-
fore, the primary purpose of this study was to assess commu-
nity leaders’ knowledge and attitudes regarding resumption
of MDA for NTDs after the EVD epidemic. We also aimed
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to identify how families and communities in the study sites
were affected by the EVD outbreak. Finally, the survey pro-
vided an opportunity to solicit feedback from the communities
themselves about how best to reengage their populations in
MDA and research activities. Information from this survey
helped us to restart the MDA study, and it may provide les-
sons for other public health programs that were suspended
during the EVD outbreak.
METHODS
Study sites. The study was conducted in 32 DOLF study
villages around Foya town in Lofa County in northwest
Liberia (Figure 1). Of these study villages, 26 were in Foya
District and six were in Kolahun District. These districts are
located near the borders of Sierra Leone and Guinea, and
many of the residents in this area frequently cross these
borders in the course of their daily activities. The districts are
endemic for onchocerciasis, LF, STH, and schistosomiasis.9
The baseline assessment of parasite infection rates and inten-
sities was completed in September 2012. MDA (albendazole,
ivermectin, and praziquantel) was distributed in December
of that year and again in June 2013 in the villages that were
assigned to semiannual MDA.
The 12-month follow-up parasitological survey of all study
villages started in January 2014. This included collection of
blood and stool samples. The survey was about two-thirds
complete by the end of March when Liberia reported the
country’s first case of EVD. DOLF management immedi-
ately suspended all research activity in this area because of
safety concerns. The DOLF team at the LIBR was unable to
return to Foya during the outbreak. Therefore, the DOLF
parasitological survey was not completed and MDA was not
provided in 2014 in our study area or anywhere in Liberia.
This study was performed in early April 2015 as the LIBR
was preparing to provide MDA that had been postponed
because of the EVD outbreak.
Questionnaire and survey procedure. The survey question-
naire included questions related to trust and community
compliance with MDA and parasitological examinations. It
also asked participants to describe how the EVD outbreak
had affected their families and communities. It was designed
to take 15–20 minutes and it included a mixture of closed-
and open-ended questions. Several iterations of the question-
naire were pretested in Monrovia and St. Louis to assess its
duration and clarity.
The survey team included the project coordinator from
LIBR, two local community health workers who provided
translation services, and two members of the project team
from Washington University in St. Louis. Four of the five
survey team members had visited the study villages before
the EVD outbreak and knew some of the residents. Villages
were notified that the team would be coming so that the
village chief and other leaders would be available. After the
leaders and other community members were assembled,
the survey team members introduced themselves, explained
the reason why the MDA and research teams had not
returned in 2014 as promised, and explained the purpose of
the survey. Each community was asked to nominate three to
five leaders who could speak on behalf of their village to par-
ticipate in the survey. Communities were asked to nominate
at least one youth leader and one female leader for the study
to include a variety of perspectives. Survey participants
included village chiefs, religious leaders, elders, and members
of women’s councils.
Participants were informed that their participation was vol-
untary and that they were free to stop the survey at any time
or skip questions that they did not want to answer. The
research was conducted as a part of the DOLF study that
operates under ethical approval from institutional review
boards at the University of Liberia-Pacific Institute for
Research and Evaluation and at Washington University.
The survey team split into two groups to conduct the
survey. One group conducted the interview in English for
those who spoke the language well. For those who could not
FIGURE 1. Map of the study area in northwestern Liberia.
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communicate in English, a second group conducted the inter-
view through a translator fluent in either Kissi or Bandi, the main
languages spoken in Foya and Kolahun districts, respectively.
Responses were collected on laptop computers using EpiInfo 7
(Centers for Disease Control and Prevention, Atlanta, GA)
and paper records were also prepared as a backup. The inter-
views were audio recorded with the permission of participants.
Survey analysis. After the survey was completed, two sur-
vey team members read through the responses to open-ended
questions and identified the emerging categories that encapsu-
lated the themes represented in the participants’ responses.
The two survey team members then independently back-
coded the open answers using these categories. To achieve
inter-rater reliability, the coding results were compared, and
the two coders came to a consensus when initial coding
results disagreed. In some cases, the audio recordings were
used to verify the meaning of responses when the written
answers were unclear. Categorical variables were compared
between groups using a χ2 test or Fisher’s exact test when
appropriate. Analyses were performed using SPSS 22 (IBM
Corporation, Armonk, NY).
RESULTS
Survey participants. A total of 140 community leaders
were interviewed in 32 DOLF study villages in Lofa County
(six in Kolahun District and 26 in Foya District) (Table 1).
Of the survey participants, 74% were male (Table 2). The
mean age of participants was 47 years (SD = 17).
Community knowledge and trust in MDA. Survey partici-
pants were generally well informed about MDA. The majority
of respondents knew the purpose of MDA, and in an open-
ended question, 124 (89%) were able to correctly name at
least one infection or related symptom treated by MDA (fila-
riasis, onchocerciasis, schistosomiasis, or intestinal worms).
The survey respondents reported that this information was
well known in their communities. When asked how many
people in their village understood the purpose of MDA,
128 (91%) selected either “plenty of people” or “everyone.”
Respondents expressed a high degree of trust in the MDA
program. Of the 131 people who remembered the last MDA
and were present in the village at that time, 130 said that
TABLE 1
Number of survey participants by village
Foya District
Bambuloe 4 Kpormbu 4
Bandenin 4 Langbamba 5
Chakporma 4 Lepaloe 4
Felaloe 6 Mendikorma 4
Fornin 4 Ngaisiakoryah* 4
Foya Dundu 4 Ngorkuma* 4
Gelema 4 Nongorchoe* 4
Kenema 4 Pehyama 5
Keyabendu 5 Sakawo 3
Kilima* 3 Sasanin 5
Kondobengu 5 Sayanin 4
Kpangbenin* 5 Sefedu 3
Kpelloe Ndama* 5 Wabengu* 5
Kolahun District
Fokolahun* 4 Kporkulahun* 4
Kamatahun* 7 Yallahun 4
Kannela 4 Yandohun* 6
*Members of the community reported family cases of Ebola outside the village.
TABLE 2
Major survey results
Demographics
Gender (N = 140)
Male 103 (73.6%)
Female 37 (26.4%)
Average age
All (N = 137) 47.3 (SD = 16.5)
Male (N = 102) 46.4 (SD = 17.1)
Female (N = 35) 49.8 (SD = 14.7)
Knowledge of MDA and Ebola
What does MDA treat? (N = 140)*
Filariasis 93 (66.4%)
Onchocerciasis 34 (24.3%)
Schistosomiasis 26 (18.6%)
Intestinal worms 21 (15.0%)
Malaria 10 (7.1%)
Other 9 (5.0%)
I do not know 8 (5.7%)
In your opinion how many people in
your community know what the
(MDA) medicine is for? (N = 140)
Everyone 58 (41.4%)
Plenty of people 70 (50.0%)
Some people 7 (5.0%)
Few people 1 (2.1%)
No one 0 (0.0%)
Do not know 2 (1.4%)
How can you get Ebola? (N = 140)*
Contact with a sick person 125 (89.3%)
Bushmeat (bat, monkey, etc.) 46 (32.9%)
Contact with a contaminated object 3 (2.1%)
Water 1 (0.7%)
I do not know 6 (4.3%)
In your opinion how many people in your
community know how Ebola is spread?
(N = 140)
Everyone 92 (65.7%)
Plenty of people 44 (31.4%)
Some people 3 (2.1%)
Few people 0 (0.0%)
No one 0 (0.0%)
Do not know 1 (0.7%)
Trust in MDA programs
Do people in your community trust the treatment
program? (N = 131)
Yes 130 (99.2%)
No 0 (0.0%)
I do not know 1 (0.8%)
Why did you answer this way?* (N = 131)
The medicine was good, it improved
health (generally)
118 (90.1%)
It improved onchocerciasis symptoms 22 (16.8%)
It improved schistosomiasis symptoms 6 (4.6%)
We know the people who provided MDA 10 (7.6%)
No one was hurt or suffered side effects 8 (6.1%)
We have been educated about MDA 7 (5.3%)
Perceived past and expected coverage
In your opinion, how many people in your
village swallowed the medicine pills given
during the last treatment? (N = 140)
4: everyone 50 (35.7%)
3: plenty of people 84 (60.0%)
2: some people 2 (1.4%)
1: few people 2 (1.4%)
0: no one 0 (0.0%)
MDAwas not delivered in my village 1 (0.7%)
Do not know 1 (0.7%)
(continued)
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they thought the community trusted the treatment program.
Trust in the program came overwhelmingly from the respon-
dent’s positive experience with treatment and feeling that the
medicine was improving health generally (N = 118, 90%)
or specifically improving symptoms related to onchocerciasis
(N = 22, 17%) or schistosomiasis (N = 6, 5%). Other answers
included that the village knew and recognized the people
who provided the MDA from previous treatments or pro-
grams and therefore trusted them (N = 10, 8%), no one suf-
fered unexpected side effects (N = 8, 6%), and the village had
been educated about the medicine and therefore was ready to
trust it (N = 7, 5%).
Perceived and expected MDA coverage. The village leaders
that we spoke with perceived past MDA coverage as high.
We asked survey participants how many people in the com-
munity they thought had swallowed the medicine during the
last MDA using the following scale: 0 = no one, 1 = few peo-
ple, 2 = some people, 3 = plenty of people, and 4 = everyone.
Most felt that plenty of people (N = 84, 60%) or everyone
(N = 50, 36%) in the town swallowed the medicine.
Most participants thought that their communities were
ready to resume MDA (N = 130, 93%), and an equal number
responded that they were willing to take the medicine if it
were delivered “today.” However, when asked how many
people they thought would swallow the medicine if it was
delivered today, many survey participants expected fewer
people would comply. A sign test was used to evaluate the
direction of change in estimated coverage scores between
the past MDA and MDA that was hypothetically delivered
today. The results showed that when asked about MDA if it
were delivered today, a significantly greater number of respon-
dents lowered their coverage estimate relative to their prior
experience (z = −5.207, P < 0.001; Table 3). On average, inter-
viewees in Kolahun District lowered their coverage estimates
more so than those in Foya District. The arithmetic mean cov-
erage score for past MDA in Kolahun was 3.44 (median = 3).
The expected mean coverage score was only 2.36 (median = 2)
if the medicine was delivered today. The difference between
scores was smaller in Foya, where the median was unchanged
at 3 and the means were 3.29 and 2.83, respectively.
Some respondents explained their reasons for expecting
that fewer people would comply with MDA. They explained
that if MDA were delivered today it would be hard to get
people to participate in the program since there had been no
advance warning. It is possible that the fall in expected cover-
age may be partly explained by the wording of the question
that led some respondents to consider the naturally lower
levels of MDA coverage associated with a surprise MDA dis-
tribution. We continued to ask the question the same way
throughout the study, though, when asked to clarify, we
explained that we would inform the community on the pur-
pose of the medicine before it would be administered.
Suggestions for improving MDA coverage. Village leaders
suggested that more community education would be necessary
to improve MDA coverage. The three most common themes
in answers to an open-ended question were the following:
1) more information or education needs to be provided
about MDA in advance of the distribution (N = 112, 80%),
2) reassure the community that the treatment is the same as
before (N = 34, 24%), and 3) explain that MDA has nothing
to do with EVD (N = 24, 17%). The frequency of these sug-
gestions varied by district. People in Kolahun were less likely
to suggest providing more information before MDA begins
(χ2[1] = 4.795, P = 0.029) but more likely to mention that it
was necessary to explain that MDA is not related to EVD
(P = 0.049; Table 4).
In total, there were 52 (37.1%) people who suggested that
we reassure communities that the treatment was the same as
before or that MDA has nothing to do with EVD. All of
these people mentioned fears within their communities about
a potential link between EVD and the MDA program,
namely that people involved in the EVD response might
spread the disease or that the medicines themselves might
cause EVD. The following quotes illustrate the fears expressed
by community leaders:
There were stories that there were vaccines given to
children who died around Ebola time. Come back
with the same people and same drugs that helped us
before and we would not fear so much and we would
take them. (Female, 43 years old)
Educate them that the medicine is to sustain health
and that the tablet is not killing them. Educate them
that it is not Ebola medicine. (Male, 25 years old)
Everybody is scaredof thisEbolabusiness.Nowpeople
are afraid of the medicine. You need to tell the people
that this medicine will help you to get well, it is filarial
medicine, not Ebola medicine. (Male, 45 years old)
Most community leaders were willing to participate in
future education campaigns. All but one answered that they
TABLE 2
Continued
In your opinion, if the medicine was delivered
to your community today, how many people
would swallow the medicine? (N = 140)
4: everyone 25 (17.9%)
3: plenty of people 65 (46.4%)
2: some people 22 (15.7%)
1: few people 13 (9.3%)
0: no one 4 (2.9%)
Do not know 11 (7.9%)
Do you think your community is ready
for another round of MDA? (N = 140)
Yes 130 (92.9%)
No 4 (2.9%)
I do not know 6 (4.3%)
Would you take the medication if MDAwere
delivered today? (N = 139)
Yes 130 (93.5%)
No 9 (6.5%)
MDA = mass drug administration; SD = standard deviation.
*Categories are not exclusive; some respondents mentioned more than one category.
TABLE 3
Changes in coverage scores when asked to estimate number of
people who swallowed the medicine at the last MDA and number
who would swallow the medicine if it was delivered today using
the following scale: 0 = no one, 1 = few people, 2 = some people,
3 = plenty of people, and 4 = everyone
Comparison of paired responses* N
Expected coverage < past perceived coverage 52
Expected coverage > past perceived coverage 10
Expected coverage = past perceived coverage 66
Total 128
*Sign test: z = −5.207, P < 0.001; rejects H0 = participants are just as or more likely to
expect positive changes as they are to expect negative changes; accepts Ha = more partici-
pants expect negative changes than positive changes.
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would promote MDA. Those who were willing to promote
MDA were asked to explain their motivation. The two most
common themes were that the “medicine is good for the
community” (N = 111, 79%) and that they wanted to serve
their community (N = 29, 21%). An emphasis on communal
benefits and duty were common in many statements such as
“I want my community to be well,” “we can promote it so
that the town can develop,” or “it is my duty.” Men were
significantly more likely to mention service to community,
with only two women citing it as a motivation (χ2(1) = 7.177,
P = 0.007). Trust in the team that delivers MDA was the
third most common motivation for promoting MDA. This
was an especially important factor motivating women’s inter-
est in promoting MDA, as they were significantly more likely
to mention this than men (P = 0.03).
Expected participation in parasitological surveys. Community
leaders expected high levels of participation in future parasito-
logical monitoring and evaluation surveys. Among the leaders
themselves, 137 (98%) said that they personally would be will-
ing to continue participating in planned examinations next
year. Respondents were asked in an open-ended question what
issues researchers could expect to face when they return to the
community. According to 40 (29%) respondents, researchers
should expect more people to participate in the examinations
than before the EVD epidemic, while 17 (12%) respondents
expected fewer people would participate due to fears from
EVD. Some respondents (N = 14, 10%) indicated that com-
munities need to be informed ahead of time about the exami-
nation so that people could be prepared and available.
Smaller numbers of respondents mentioned that the commu-
nity would like to see their results from the last survey (N = 4,
3%). Importantly, a few leaders stated that the medicine
promised after the last examination must come before the
community would be willing to participate in further parasito-
logical examinations (N = 4, 3%).
Again, there were differences between the districts. Respon-
dents from Kolahun were less likely to think that researchers
should expect a higher turnout than before (χ2(1) = 8.420,
P = 0.004) and were more likely to think that that fear of
EVD would keep people from participating in parasitological
examinations (P = 0.002).
Ebola’s impact on study villages. Nearly everyone (N = 138,
99%) said they knew about EVD. When asked to describe
how someone can get EVD, 132 (94%) respondents named
at least one of the transmission pathways emphasized by the
Ministry of Health and World Health Organization: contact
with a sick person (N = 125, 89.3%), contact with bushmeat
(N = 46, 32.9%), or contact with a contaminated object (N = 3,
2.1%). Bushmeat was most often specified as monkey and bat.
Respondents were confident that this information was widely
known in their villages, with 136 (97%) answering that plenty
of people or everyone knew how Ebola could be spread.
Fortunately, respondents did not report any cases of trans-
mission of EVD within the DOLF study villages. However,
survey respondents in two Foya District villages told us that
some village members were diagnosed with EVD while travel-
ing or working nearby. In Kilima, a border town about 3 km
from Sierra Leone, several community members had traveled
to Sierra Leone, where they became sick. Some died there,
while one person received treatment and survived. InNgorkuma,
located 12 km north of Foya, a member of the commu-
nity who worked at Foya Hospital contracted EVD and
died after he cared for an infected woman who had
crossed the border from Guinea. His daughter also died
after contracting the disease. According to community
health workers on the survey research team, who were
involved in contact tracing during the outbreak, these
were likely the first locally transmitted cases in Liberia.
Neither the hospital worker nor his daughter stayed in
Ngorkuma while they were ill.
Seventeen respondents told us that they had family mem-
bers who had contracted EVD. All of the reported family
cases of EVD occurred outside their home villages, mostly in
Monrovia. A disproportionate number of these cases were in
people whose home villages were in Kolahun District. Of
respondents with infected familymembers, 41% (7 of 17) resided
TABLE 4
Community leader expectations regarding MDA and the research project by district
Foya (N = 111) Kolahun (N = 29)
n (%) n (%)
What do you think would convince more members of your community to comply with MDA and swallow or take the medicines?*
Sensitize people before MDA (general education)† 93 (83.9) 19 (65.5)
Explain that the MDA is not Ebola related‡ 15 (13.5) 9 (31.0)
Provide reassurance that procedures are similar to previous MDA 28 (25.2) 6 (20.7)
Use people from the village to share the message and educate the community 7 (6.3) 5 (17.2)
Use community health workers or GCHVs to educate people 3 (2.7) 2 (6.9)
Make a radio announcement 3 (2.7) 0 (0.0)
The drug distributors should take the medicine in front of the community 1 (0.9) 1 (3.4)
Nothing needs to be done 3 (2.7) 0 (0.0)
In your opinion, what issues do you expect the research team to face if they return to work in your community?*
There will be no problems 50 (45.0) 13 (44.8)
More people will participate than before† 38 (34.2) 2 (6.9)
Few people will participate‡ 8 (7.2) 9 (31.0)
The village needs to be told when the researchers are coming 9 (8.1) 5 (17.2)
The village needs to get past results before they participate in exams 4 (3.6) 0 (0.0)
The village needs to receive medicine before any examination 4 (3.6) 0 (0.0)
There are other problems that have been neglected besides filaria 1 (0.9) 0 (0.0)
Access to the village will be difficult 1 (0.9) 0 (0.0)
MDA = mass drug administration; GCHVs = general community health volunteers.
*Categories are not exclusive; some respondents mentioned more than one category.
†Significantly different at P < 0.05 level for χ2 test.
‡Significantly different at P < 0.05 level for Fisher’s exact test.
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in Kolahun District where only 21% of the 140 interviews
were performed. Only seven of twenty-six (27%) study villages
in Foya District had respondents with affected family members
compared with four of six (66%) study villages in Kolahun.
DISCUSSION
This study collected data about community perceptions of
MDA for NTDs after the EVD outbreak in villages near an
early epicenter of the outbreak. The results have important
implications for NTD and other public health programs in
the three countries severely affected by EVD. The most
important and encouraging result was the continued enthusi-
asm for MDA and a willingness to continue participation in
parasitological examinations after the outbreak of EVD. More
than 90% of all the community leaders who participated in
the survey felt that their community was ready for MDA and
were personally willing to swallow the medications or partici-
pate in the examinations. In addition, respondents expressed
high levels of community trust in the MDA programs. Even
though 2 years had passed since the last round of MDA was
delivered in some villages, respondents still credited the
MDA program with improvements in health and were there-
fore willing to continue trusting the program. These over-
whelming positive responses should bode well for MDA
programs and suggest a strong support and desire among
Liberians for the resumption of this public health program.
Although our results suggest that there is significant public
support for the resumption of NTD control and elimination
programs, they also suggest that programs should not assume
that they can resume their routine activities as if nothing
happened. Survey participants expected fewer people would
comply with MDA when compared with the last distribution
prior to the epidemic, voicing concerns from within the com-
munity about a link between MDA and EVD. Even as they
stated that their villages were ready for MDA approximately
one in three respondents suggested that fears about EVD
would need to be overcome to improve coverage results. If
these fears are not addressed when MDA programs resume,
they may encounter lower than expected cooperation and
compliance. This may be especially true in areas that were
more directly affected by EVD.
Although there was no EVD transmission in our study vil-
lages, many people reported EVD cases in family members
who lived outside their villages. This situation is likely to be
typical for the majority of villages in the study area and
nearby villages in Sierra Leone and Guinea. We encountered
greater skepticism about MDA programs in Kolahun District,
where a greater proportion of respondents reported having
family members affected by EVD. Compared with Foya,
respondents in Kolahun District were more concerned about
making it clear that MDA and EVD are unrelated, and they
expected a greater drop in coverage and participation in para-
sitological surveys because of fear of EVD. These results sug-
gest that a positive relationship may exist between more
direct encounters with EVD and suspicion that MDA pro-
grams could intentionally or inadvertently spread the disease.
Several themes emerged from our survey that point to
strategies that could calm these fears and help MDA pro-
grams reengage communities and improve MDA compliance.
Respondents were knowledgeable about the purpose of
MDA and modes of EVD infection. Promoting this existing
knowledge and their past experience with MDA could reas-
sure people that MDA has nothing to do with EVD. Since
past experiences with the MDA program seem to be the
basis for a large part of the communities’ trust in MDA,
these programs should emphasize their past work. In particu-
lar, respondents thought that reminding the community that
they have taken the same treatment before and that it was
helpful would be a convincing message. Involving community
members in these promotional messaging campaigns could
be particularly effective. Previous research has shown how
community involvement and ownership in MDA programs
can achieve higher coverage rates, particularly in Africa.10,11
Our results underscore these findings, since including commu-
nity members in MDA promotion activities was the most
commonly suggested outreach method for improving MDA
coverage. Many community leaders we surveyed seemed will-
ing to promote MDA because they valued the collective bene-
fits to the community. These motivations rooted in social
norms that value duty and protecting the community can be
important to an individual’s decision to comply with MDA.12
Unlike many other health behavior campaigns that seek to
motivate individuals, MDA is a community event that should
be linked to the social behavior and identity of the group.
Social norms played an important role in curbing the EVD
outbreak in Liberia. Once the threat of EVD was under-
stood, communities changed their burial practices, washed
hands more frequently, and stopped shaking hands. Commu-
nity leaders were often seen as the “driving force” of these
initiatives.13 After the outbreak, the message should be that
MDA is a similar protective action that requires everyone’s
participation to protect the community from disease. Leaders
or other influential members of the community should once
again play an important role in communicating these messages.
This promotional messaging coupled with small practical
changes to the MDA program (e.g., providing water in indi-
vidual disposable paper cups for swallowing pills) should
help to overcome fears surrounding MDA.
Our survey of community leaders quickly provided useful
information related to the resumption of health programs that
had been disrupted by the EVD outbreak. However, because
of the limitation of the survey design the results should be
interpreted with caution. The survey participants were a pur-
posive sample of influential community leaders who could
speak on behalf of the community. They were not a random
sample of community members. Therefore, the results may
not accurately represent opinions and sentiments of residents
of the study villages. However, we attempted to include a diverse
representation of community voices by including at least one
youth and female leader in all but one village survey. Another
limitation of our study was that it was conducted prior to resump-
tion ofMDA. Attitudes may change after MDA, and it would be
interesting to conduct coverage surveys to determine how accu-
rately participants’ predictions matched with actual results.
With these limitations in mind, results of our study suggested
that 32 communities in Foya and Kolahun districts were
ready to resume MDA after the EVD outbreak, although a
minority of survey participants suggested that there was fear
in the community about a link between EVD and MDA.
When MDA programs resume, they should address these
fears early to avoid problems with compliance. This might be
especially true in areas that experienced intense EVD trans-
mission. Strategies to overcome these fears should emphasize
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the community’s past experiences with MDA and enlist mem-
bers of the community to promote and champion the program.
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